Trial intelligence / Profile preview

PHENO-FILM: 1% Phenytoin Mucoadhesive Film for Oral Ulcers

NCT07890428Phase 1Not yet recruiting

Sponsor
Misr University for Science and Technology
Start
Oct 2026
Primary completion
Nov 2026
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of phenytoin in Oral ulcer, oral mucositis (OM) and aphthous stomatitis (RAS) (2 arms), sponsored by Misr University for Science and Technology. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 7 days. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

phenytoin
03

Conditions

Oral ulceroral mucositis (OM)aphthous stomatitis (RAS)

Beyond the preview

Go deeper on NCT07890428.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07890428.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call